期刊文献+

结直肠癌中p16基因的甲基化改变与蛋白表达的关系 被引量:7

Study on the aberrant methylation and protein of p16 gene in patients with colorectal cancer
原文传递
导出
摘要 目的 检测结直肠癌患者肿瘤组织中p16基因启动子区异常甲基化改变及蛋白表达情况,探讨其与结直肠癌发生发展与临床的关系。方法 采用甲基化特异PCR(MSP)和免疫组织化学链霉素过氧化物酶(SP)方法,对32份结直肠癌标本p16基因甲基化改变及蛋白表达情况进行检测分析。结果 p16甲基化阳性率为40.6%;p16蛋白表达阳性率75.0%;在病理分期中,DukesC、D期患者肿瘤组织中p16甲基化发生率63.0%,p16蛋白表达发生率为69.0%;DukesA、B期患者p16甲基化发生率为25.0%,p16蛋白表达阳性率为81.0%;在组织分化程度中,低分化癌中的p16甲基化阳性率为100.0%,p16蛋白表达阳性率为20.0%;在高、中分化癌中,p16甲基化的阳性率为30.0%,p16蛋13表达阳性率为85.0%;淋巴结转移癌患者肿瘤组织中p16基因甲基化阳性率为63.0%,淋巴结未转移的阳性率为25.0%;在肿瘤部位中,直肠癌p16蛋白表达阳性率为65.0%,结肠癌的阳性率为100.0%。结论 p16甲基化的改变可能影响p16蛋白的表达;p16甲基化、蛋白表达与结直肠癌的发生发展密切相关,p16甲基化和蛋白表达是结直肠癌患者诊断及预后的候选标志物之一。 Objective To explore whether hypermethylation in the promoter of p16 gene and protein of p16 were associated with development and clinicopathological characteristics of colorectal cancer. Methods Methylation-specific PCR ( MSP) and immunohistochemistry SP were used to detected hypermethylation of p16 gene and p16 protein in tumor tissues from 32 patients with colorectal cancer. Results The hypermethylation of p16 gene was detected in 40. 6% of tumor tissues. The protein of p16 promoter was detected in 75% of tumor tissues. The hypermethylation of p16 gene was detected in 63% in Dukes stages of C and D tumors. The protein of p16 promoter was detected in 69% of tumor tissues. The hypermethylation of p16 gene was detected in 25% in the stages of A and B tumors. The protein of p16 promoter was detected in 81% of tumor tissues. The hpermethylation of p16 gene was detected in 100% in low differentiated carcinomas. The protein of p16 promoter was detected in 20% , the hypermethylation of p16 gene was detected in 30% , in the high and mediate differentiated carcinomas, the protein of p16 promoter was detected in 85%. Furthermore, the hypermethylation of p16 gene was detected in 63% in the lymph node metastasis and 25% in without lymph node metastasis. The protein of p16 promoter was detected in 65% in rectum and 100% in colon. Conclusions Our study demonstrated that p16 hypermethylation and protein were associated with the development of colorectal cancer and could be used as a putative prognostic indicator for this malignancy.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2004年第5期307-310,共4页 Chinese Journal of Laboratory Medicine
基金 日本文部省"中日韩三国结直肠癌食物危险因素和保护因素研究"
关键词 结直肠癌 P16基因 甲基化 蛋白表达 Colorectal neoplasms Genes, p16 Methylation
  • 相关文献

参考文献13

  • 1Kamb A, Gruis NA, Weaver-feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994,264:436-440.
  • 2Nobori T, Miura K, Wu DJ, et al. Detection of the cyclin dependent kinase-4 inhibitor gene in multiple human cancers Nature, 1994,368:753-756.
  • 3Gonzalez ZM, Bender CM, Yang AS, et al. Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlation with gene silencing . Cancer Res , 1995, 55:4531-4535.
  • 4Guan R J, Fu YN, Holt PR, et al. Association of K-ras mutation with p16 methylation in human colon cancer . Gastroenierology,1999, 116:1063-1071.
  • 5Herman JG, Jeremy RG, Sanna M, et al. Methylation-specific PCR: a novel PCR assay for methylation status for CpG islands. Proc Natl Acad Sci USA, 1996,93:9821-9826.
  • 6Rocco J W, Sidransky D. p16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res, 2001, 264: 42-55.
  • 7Baylin SB, Herman JG, Mao L, et al. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancer. Nat Med, 1995,1:686-692.
  • 8Liang JT, Chang KJ, Cheng JC, et al. Hypermethylation of the p16 gene in sporadic 13 N0:M0: stage colorectal cancer: association with DNA replication error and shorter survival. Oncology, 1999,57:149-156.
  • 9Esteller M, Tortola S, Toyota M, et al. Hypermethylation-associated inactivation of p14 (AFR) is independent of p16 (INK4a)methylation and p53 mutational status. Cancer Res, 2000,60: 129-133.
  • 10Wienoke JK, Zheng S, Latuente A, et al. Aberrant methylation of p16 INK4a in atatomic and gender-specific suntypes of sporadic colorectal cancer. Cancer Epidemic Biomarker Prey, 1999,8: 501-506.

二级参考文献27

  • 1[1]Jen J,Harper W,Bigner SH,et al.Delection of p16 and p16 genes in brain tumors [J].Cancer Res,1994,54:6353.
  • 2[2]Wiencke JK,Zheng S,Lafuente A,et al .Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer[J].Cancer Epidemiol Biomarker & Prey,1999,8:501.
  • 3[3]Peter W,Laird,Rudolf Jaenisch,et al.The role cf DNA methylation in cancer genetics and epigenetics[J].Annu Rev Genet,1996,30:441.
  • 4[4]Baylin SB,Herman JG,Graff JR,et al.Alterations in DNA methylation:A fundamental aspect of neoplasia [J].Adv Cancer Res,1998,72:141.
  • 5[5]Herman JG,Jeremy R.Greff,Sanna M,et al.Methylation-specific PCR:A novel PCR assay for methylation status of CpG islands [J].Proc Natl Acad Sci USA,1996,93:9821.
  • 6[6]Rong J,Yineng Fu,Peter R,et al.Association of K-ras mutations with p16 methylation in human colon cancer [J].Gastroenterology,1999,116:1063.
  • 7[7]Liang JT,Chang K J,Chen JC,et al.Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers:association with DNA replication error and shorter survival[J].Oncology,1999,57:149.
  • 8[8]Esteller M,Tortola S,Toyota M,et al.Hypermethylation-associated inactivation of p14(ARF) is independent of p16 (INK4a) methylation and p53 mutational status[J].Cancer Res,2000,60:129.
  • 9[9]Merlo A,Herman JG,Mao L,et al.5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers[J].Nature Medicine,1995,1:686.
  • 10[10]Gonzalez-Zulueta M,Bender CM,Yang AS,et al.Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing[J].Cancer Res,1995,55:4531.

共引文献5

同被引文献78

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部